Table 7 Outcomes and outcome measurements identified in the ‘Adverse events’ domain for PGP and LPP respectively
| Adverse Events | PGP studies (n = 33) | LPP studies (74) |
|---|---|---|
| Adverse events (not specified) | Patient Questionnaire [115] |
Case reports by physio [86] Identified by trialist [12] Not specified [56, 59, 70, 71, 93, 95] Questionnaire [85, 104] |
| Post-op complications | Not specified [117] | |
| Fetal outcome | Apgar score, birth weight, perinatal loss [84] | |
| Safety of women and children | Not specified [114] |